IHH Healthcare Bhd.

IHH Healthcare Bhd.'s next confirmed earnings release is scheduled for November 26, 2026.

As of June 30, 2026, IHH Healthcare Bhd. has 8.84B shares outstanding.

As of June 30, 2026, IHH Healthcare Bhd. trades at a trailing price-to-earnings ratio of 33.06. The price-to-sales ratio is 2.77, and the price-to-book ratio stands at 2.37.

As of June 30, 2026, IHH Healthcare Bhd. trades at an EV/EBITDA multiple of 22.11 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.42 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 22.11 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. IHH Healthcare Bhd. trades at an EV/FCF ratio of 9.73, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of June 30, 2026, IHH Healthcare Bhd. maintains a current ratio of 0.58, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 43.14, indicating elevated leverage, while an interest coverage ratio of 4.03 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, IHH Healthcare Bhd. posted a return on equity (ROE) of 7.27, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 5.86 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 3.88, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 4.82, useful for judging operating efficiency across full business cycles. Inventory turnover of 8.25 indicates how many times IHH Healthcare Bhd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

These figures cover the twelve months ended June 30, 2026. That works out to an effective tax rate of 28.66, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

As of the close on October 22, 2026, IHH Healthcare Bhd.'s stock has declined approximately 3.97% over the past 52 weeks. The 50-day moving average sits at 7.98, while the 200-day moving average is 8.54.

Over the twelve months ended June 30, 2026, IHH Healthcare Bhd. posted a gross margin of 72.15, reflecting its pricing power and cost economics. The operating margin of 15.45 and net profit margin of 8.39 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. The dividend payout ratio of 13.07 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 11.66, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 3.45, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to IHH Healthcare Bhd. shareholders.

As of June 30, 2026, IHH Healthcare Bhd. has an Altman Z-Score of 3.20, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.